BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
13.19
-0.11 (-0.83%)
At close: Jan 9, 2026, 4:00 PM EST
13.19
0.00 (0.00%)
After-hours: Jan 9, 2026, 5:32 PM EST
BBOT Market Cap
BBOT has a market cap or net worth of $1.06 billion as of January 9, 2026. Its market cap has increased by 330.49% in one year.
Market Cap
1.06B
Enterprise Value
626.45M
1-Year Change
330.49%
Ranking
Category
Stock Price
$13.19
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $1.06B, an increase of 2,661.01%. That is a compound annual growth rate of 465.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 1.06B | 6.23% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |